SIRT1 and endometrial carcinoma: p53 is an important target protein for SIRT1.Previous study indicated that the selective SIRT1 inhibitor, EX527, significantly suppressed the proliferation of endometrial carcinoma cells regardless of the p53 mutation status 52,53.